AbbVie Inc. (ABBV) vs Dell Technologies Inc. (DELL)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Dell Technologies Inc. is a diversified information technology company that primarily provides hardware solutions to enterprise customers. The company focuses on premium and commercial PCs, along with on-premises data center infrastructure for businesses. Dell maintains top-three market positions in its key segments, including personal computers, display peripherals, mainstream servers, and external storage. It benefits from a strong network of component suppliers and assembly partners, while also relying extensively on channel partners to support product sales and distribution.